DEPRESSANT, ANTICONVULSANT AND ANTIBACTERIAL ACTIVITIES OF HIPPOCRATEA AFRICANA
description
Transcript of DEPRESSANT, ANTICONVULSANT AND ANTIBACTERIAL ACTIVITIES OF HIPPOCRATEA AFRICANA
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 144 ~
e - ISSN - 2249-7722
Print ISSN - 2249-7730
International Journal of Phytotherapy
www.phytotherapyjournal.com
DEPRESSANT, ANTICONVULSANT AND ANTIBACTERIAL
ACTIVITIES OF HIPPOCRATEA AFRICANA
*Jude E. Okokon1, Koofreh Davies
2, Bassey S. Antia
3, Patience J. Okokon
1
1Department of Pharmacology and Toxicology Faculty of Pharmacy, University of Uyo, Uyo, Nigeria.
2Department of Physiology, Faculty of Basic Medical Sciences, University of Uyo. 3Department of Chemistry, Faculty of Sciences, University of Uyo, Uyo, Nigeria.
INTRODUCTION
Hippocratea africana (Willd.) Loes.ex Engl.
(Celastraceae) syn. Loeseneriella africana (Willd.)
N.Hallis a green forest perennial climber without hairs
(glabrous), reproducing from seeds [1]. It is commonly
known as African paddle-pod. The Ibibio tribe of Nigeria
calls it Ebaenangenang. The plant is widely distributed in tropical Africa. The root of the plant is used
traditionally by the Ibibios of the Niger Delta region of
Nigeria in the treatment of various ailments such asfever,
convulsion, malaria, body pains, diabetes and diarrhea
[2]. Ethnobotanical survey revealed that decoction of the
plants root is also use as an antidote or antipoison to treat liver and inflammatory diseases such as jaundice and
hepatitis [3-5].The plant (root) has been reported by
Okokon et al [2] to possess in vivo anti-plasmodial
activity. Other biological activities include; anti-
inflammatory and analgesic [6], anti-diarrheal, antiulcer
[7], anti-diabetic and hypolipidemic activities
Corresponding Author:-Jude E. Okokon Email: [email protected]
ABSTRACT
Hippocratea africana (Willd.) Loes.ex Engl. (Celastraceae) is used locally to treat convulsion and
microbial infections. The root extract of Hippocratea africana was evaluated for depressant effect and antimicrobial
activity.Depressant activity was evaluated using open field, force swimming, tail suspension tests and
phenobarbitone-induced sleeping time. Anticonvulsant activity was testedagainst pentylenetetrazol and
aminophylline-induced convulsions. The root extract/fractions were screened for antimicrobial activity against
some typed and pure cultures of bacterial and fungal species using Plate -hole diffusion methodon Mueller Hinton agar (MHA) for bacteria and Sabouraud Dextrose Agar (SDA) for the fungi. Minimum Inhibitory Concentrations
(MICs) of active test samples were determined. The root extract decreased significantly (p
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 145 ~
[8], cytotoxicity against HeLa cells, anti-oxidative burst
and anti-leishmanial activities [9] and hepatoprotective
activity [10]. In this study, we report the anticonvulsant
and antibacterial activities of the root extract of
Hippocratea africana.
MATERIALS AND METHODS
Plant materials
Fresh roots of H.africana were collected in
August, 2014 at a forest in Uruan, Akwa Ibom State,
Nigeria. The plant was identified and authenticated by
Dr. Margaret Bassey, a taxonomist in the Department of
Botany, University of Uyo, Uyo. Nigeria. Herbarium
specimen was deposited atFaculty of Pharmacy
Herbarium.
Microorganisms
Typed and pure cultures of some bacterial and
fungal species were obtained from Pharmaceutical
microbiology unit of the Department of Pharmaceutics
and Pharmaceutical Technology, Faculty of Pharmacy,
University of Uyo, Uyo and maintained at 40oC on
nutrient agar plates before use.
Extraction
The root materialswere washed and shade-dried
for two weeks. The dried plants materials were further chopped into small pieces and reduced to powder. The
powdered material was soaked in 70% ethanol. The liquid
filtrate was concentrated and evaporated to dryness in
vacuo 40C using rotary evaporator. The crude ethanolic extract (10 g) was partitioned with a 50:50 mixture of
distilled water and chloroform. The aqueous fraction was
evaporated to dryness in a water bath at 60OC and the
chloroform fraction air-dried. The ethanolic extract, the
aqueous and chloroform fractions were stored at -4OC
until used.
Animals
The animals (Swiss albino mice of either sex)
that were used for these experiments were obtained from
University of Uyo animal house. The animals were
housed in standard cages and were maintained on a
standard pelleted feed (Guinea feed) and water ad libitum.
Permission and approval for animal studies were obtained
from College of Health Sciences Animal Ethics
committee, University of Uyo.
Evaluation of Depressant activity
Open Field test
Rats were randomly divided into groups of 5 rats
each and treated as follows for 5 days before open field
test; control (normal saline, 2 ml/kg p.o.), imipramine
(5.0 mg/kg, p.o.) and ethanolic root extract of
Hippocratea africana (200, 400 and 600 mg/kg, p.o.).
The open-field arena was made of acrylic (transparent
walls and black floor, 30 30 15 cm), divided into nine
squares of equal areas. The open field was used to
evaluate the exploratory activity of the animal [11]. The
observed parameters were the number of squares crossed
(with the four paws) and number of grooming and rearing,
recorded for 5 min testing period.
Forced Swimming test
Mice were randomly divided into groups of 5
mice each and treated as follows for 5 days before the
behavioural test; control (normal saline, 2 ml/kg p.o.),
imipramine (5.0 mg/kg, p.o.) and ethanolic root extract of
Hippocratea africana (200, 400 and 600 mg/kg, p.o.). For
assessing antidepressant activities, we employed the
method described by Porsolt et al [12,13]. The
development of immobility when mice were placed inside
an inescapable cylinder filled with water reflects the
cessation of persistent escape-directed behavior. Briefly,
mice were individually placed in a circular tank (46 cm
tall 20 cm in diameter) filled with tap water (25 1C)
to a depth of 20 cm and left there for 5 min. During this
period, the behavior of the animals was recorded by an
observer. Mice were considered immobile when remained
floating without struggling and making only slight
movements necessary to maintain the head above the
water.
Tail Suspension test (TST)
Mice of either sex were randomly divided into
groups of 5 mice each and treated as follows for 5 days
before open field test; control (normal saline, 2 ml/kg
p.o.), imipramine (5.0 mg/kg, p.o.) and ethanolic root
extract of Hippocratea africana (200, 400 and 600 mg/kg,
p.o.). The total duration of immobility induced by tail
suspension was measured according to the methods
described by Steru et al [14]. Briefly, mice both
acoustically and visually isolated were suspended 50 cm
above the floor by adhesive tape placed approximately
1 cm from the tip of the tail. Immobility time was
recorded during a 6 min period. Mice were considered
immobile only when they hung passively and were
motionless.
Anticonvulsant activity
Pentylenetetrazol induced Convulsion
Anticonvulsant effect of the extract was assessed
using a modified method of Vellucci and Webster [15] on
overnight fasted mice. The mice were divided into seven
groups of six animals each and treated with 200, 400 and
600 mg/kg of the root extract, 400 mg/kg of chloroform
and aqueous respectively, phenytoin, 40 mg/kg one hour
before induction of convulsion. Seizure was induced in
each set of mice with PTZ (70 mg/kg i.p). Control group
received normal saline. The onset of Clonic/tonic
convulsion and the mortality rate was recorded and
compared with the respective control group. The ability of
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 146 ~
the plant extract to prevent or delay the onset of the hind
limb extension exhibited by the animals was taken as an
indication of anticonvulsant activity [16].
Aminophylline-induced Convulsion
The extract and fractions were evaluated for
aminophylline induced convulsion using the method of Juliet et al [17].The mice were divided into seven groups
of six animals each and treated with 200, 400 and 600
mg/kg of the extract 400 mg/kg of chloroform and
aqueous respectively, phenytoin, 40 mg/kg one hour
before induction of convulsion. Seizure was induced
using aminophylline (280 mg/kg,i.p). The animals were
observed for 120 mins after the administration of AMPH
and the following parameters were noted:
1. Time to onset of myoclonic jerks in mins. 2. Time to onset of tonic convulsions in mins. 3. Time to death during experimental time of 120 mins. 4. Number of mice dead/alive at 24 hours.
Effect on phenobarbitone induced sleeping time of rats
The crude ethanolic extract was evaluated for
effect on phenobarbitone sodium sleeping time of rats.
The rats were divided into five groups of five rats each
(n=5). The extract (200, 400 and 600 mg/kg) was
administered to various groups of rats, diazepam (2
mg/kg) was given to the reference group and the control
group was given distilled water (10 ml/kg). After 30 min
the groups were treated with phenobarbitone sodium (40
mg/kg,i.p). The onset and the duration of sleep were noted
and recorded in minutes.
Evaluation of antibacterial and antifungal activities of
the extract
Plate-hole diffusion test
The evaluation of antimicrobial activity of the
extract/fractions were carried out by the Plate -hole
diffusion method [18] on Mueller Hinton agar (MHA) for bacteria and Sabouraud Dextrose Agar (SDA) for the
fungi. Solutions of the extract and fractions were prepared
in 10% Tween 80 to concentrations of 100, 50, 25 and
12.5mg/ml.
The innocula of the microorganisms were
prepared separately from 12h broth cultures (Mueller-
Hinton broth for bacteria and the Sabouraud dextrose
broth for the fungi) and incubated at 37C. All culture
media and distilled water were sterilized at 121C for 15 min in an autoclave. These innocula were diluted with
sterilized distilled water to obtain a density corresponding
approximately to 0.5 of McFarland standard turbidity
scale (108 colony forming unit CFU per ml for the
bacteria and 103 spores per ml for fungi)[18]. 0.5 ml of
each innoculum was introduced into the corresponding
fluid agar medium homogenized and 25 ml of it poured
into sterile plastic petridishes. The petridishes were
allowed on the flat slab top for the medium to solidify
within 30 min. A standard cork borer of 5mm in diameter
was used to cut four equidistant uniform wells per plate
on the surface of different plates into which was added
50l solution of each extract/fraction at varying concentration 12.5, 25, 50 and 100 mg/ml. The reference
drugs were Gentamicin, batch 20070402 (0.4 mg/ml) and
Nystatin batch 04D05 (500 g/ml). The plates were
incubated at 37C for 24 and 48h for the bacteria and fungi respectively. The antimicrobial activity was
evaluated by measuring the zone of inhibition around the
hole. Each test concentration had three replications. The
results were recorded as the mean diameter of the zones
of growth inhibition surrounding the discs [19].
Determination of minimum inhibitory concentrations
(MIC) using macrodilution method
The Minimum Inhibitory Concentrations (MICs)
of test samples found to be active by the diffusion test
were determined based on the macrodilution method [18]
with some modifications as follows. The test
extract/fractions were dissolved in 10% Tween 80 to give
a stock concentration of 100mg/ml and serially diluted
(two-fold) in a seres of test tubes to a working
concentration ranging from 1.560 to 100mg/ml using
nutrient broth supplemented with 10% glucose and 0.05%
phenol red (colour indicator). These were later inoculated
with 0.2ml suspension of the test organisms. Microbial
growth was determined by observing for color change in
the tube (red to yellow when there is growth). The lowest
concentration that showed no change of color was
considered as the MIC.
Statistical Analysis and Data Evaluation
Data obtained from this work were analyzed
statistically using one way ANOVA followed by a post
test (Turkey-Kramer multiple comparison test).
Differences between means was considered significant at
1% and 5% level of significance, that is P 0.01and 0.05
RESULTS
Open field test
Administration of root extract of H. africana
(200 600 mg/kg) for 5 days caused significant (p
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 147 ~
no effect on the locomotor activity of the rats. The
standard drug, imipramine (5 mg/kg), produced a
significant (p
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 148 ~
Table 2. Anticonvulsant Activity of Hippocratea africana root extract on PTZ- induced convulsion
Data are represented as mean SEM .significant at aP < 0.05;bp
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 149 ~
Table 5. Minimum inhibitory concentration of ethanolic crude root extract and fractions of H. africana (mg/ml).
Organism Crude Extract/ Fraction
Ethanolic Crude Extract Aqueous Chloroform
Staph. aureus NCTC 6571 10 6.5 3.125
Bacillus subtilis NCTC 8853 30 7.0 3.125
Pseudomonas aureginosa ATCC 27853 - 30 -
Figure 1. Bar diagram showing the effect of Hippocratea
africana root extract on line crossing frequency of rat
Results are represented as mean SEM with n = 5 in each group. *p
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 150 ~
Effect of the crude extract and fractions of H. Africana
on some microorganisms
Table 4 shows the diameters of the zones of
inhibition exhibited by ethanolic crude extract and
fractions at various concentrations employed. The crude
extract, chloroform and aqueous fractions showed a
narrow spectrum of activity against gram positive Staph
aureus (NCTC 6571) and Bacillus subtilis (NCTC 8853).
Pseudomonas aeroginosa (ATCC 27853) was the only
gram negative bacteria tested that was sensitive to the
aqueous fraction. The chloroform fraction had the highest
activity against both Staph aureus and Bacillus subtilis
followed by aqueous fraction and the crude extract. Other
tested organisms were not sensitive to either the crude
extract or fractions..The activities of the crude
extract/fractions were not comparable to that of the
standard, streptomycin. The crude extract and the
fractions were inactive against all fungal species tested.
The results of minimum inhibitory concentrations
(MIC)of the crude / fraction are shown in Table 5. The
lowest MICs of chloroform fraction (3.125 mg/ml) were
recorded against B.subtilis (NCTC 8853) and Staph.
Aureus (NCTC 6571). While the MICs of aqueous
fraction against B. subtilis and Staph aureus were 7.0 and
6.5 mg/ml respectively. Aqueous fraction also inhibited P.
aeruginosa with MIC value of 30.0 mg/ml.
DISCUSSION
In this study, evaluation of the effect of ethanolic
root extract on central nervous system was carried out in
rats using different models; Open field test, tail
suspension test and force swimming test. The root extract
(200 600 mg/kg) was found to cause significant dose dependent reductions in the frequency of line crossing and
rearing activities of the pretreated rats, while the walling
frequency was significantly (p
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 151 ~
delay the onset of tonic/clonic convulsions and prolonged
the time of the death of the treated mice against
pentylenetetrazol and aminophylline induced convulsions.
The aqueous fraction was observed to have the highest
activity.
The exact mechanisms of seizures induced by
aminophylline appear to be diverse, multiple and
complex, and also unclear. Evidence suggests that
seizures induced by aminophylline, could be the result of
adenosine receptor antagonism or due to inhibition of
cerebral nucleotidase activity [30, 31], which lower the
adenosine content in the brain and eventually lead to a
process of disinhibition. However, report has it that di-
phenylhydantoin a potent inhibitor of adenosine uptake
was ineffective in preventing these seizures [32]. Apart
from non-specific adenosine receptor antagonism [33],
aminophylline is thought to have inhibitory influence on
adenosine synthesis. At higher doses inhibition of
phosphodiesterase activity including mobilization of
intracellular calcium ions from labile stores are said to be
implicated in AMPH-induced seizures [34, 35]. However,
a report by Ray et al., [36], has implicated oxidative stress
due to the generation of free radicals and reactive oxygen
species to be responsible for the seizures induced by
aminophylline.
Hippocratea africana root extract and fraction
which was observed to delay the onset of aminophylline
induced convulsion, has been reported to contain -thujene , sabinene and sesquiterpenes, which have been
implicated in the anticonvulsant activities of plants
[37,38]. These compounds may be responsible for the
observed anticonvulsant activity of the plant. Also,
Okokon et al. [10] reported the antioxidative property of
the root extract. The antioxidant activity of this root
extract may be responsible for the observed protection
against aminophylline induced convulsion.
According to De Sarro et al.,[39],
pentylenetetrazol (PTZ)is suggested to exert its
anticonvulsant effect by inhibiting the activity of gamma
aminobutyric acid (GABA) at GABAA receptors. Gamma
aminobutyric acid is the major inhibitory neurotransmitter
which is implicated in epilepsy. The enhancement and
inhibition of the neurotransmission of GABA will
attenuate and enhance convulsion respectively [40,41].
Phenobarbitone and diazepam, standard epileptic
drugs,have been shown to exert their antiepileptic effects
by enhancing GABA-mediated inhibition in the brain
[42,43]. These drugs are reported to antagonise PTZ-
induced convulsion [44] by enhancing GABA
neurotransmission. Phenytoin was unable to prevent PTZ-
induced seizure because it is thought to exert its
antiepileptic effect by blocking sodium ions into brain
cells thus inhibiting generation of repitative action
potential [42]. Since the root extract and fractions of
Hippocratea africana were able to delay PTZ induced convulsion it is probable that they may be interfering with
gabaergic mechanism(s) to exert its effect. Their
anticonvulsant activities are due to their phytochemical
components as reported above.
The ethanol root extract of H. africana was
found to significantly enhanced duration of the
phenobarbitone sodium -induced hypnotic effect, which
was observed in the shortening of time of onset of sleep
and prolonging the duration of sleep following its
administration suggesting a depressant activity on the
CNS. Substances which possess CNS depressant activity
either decrease the time for onset of sleep or prolong the
duration of sleep or both [45, 46]. A prolongation of the
phenobarbitone effect could involve a facilitation of
GABA mediated postsynaptic inhibition through
allosteric modification of GABAA receptors.
The root extract and fractions were found to
exert antibacterial activity against Gram positive S.
aureus and B. subtilis as well as Gram negative P.
aureginosa. This activity may have resulted from the
presence of phytochemical compounds such as
monoterpenes (thujene and sabinene) and sesquiterpenes
as reported above.
Compounds such as terpenes (mono and
sesquiterpenes) which have been implicated in
antibacterial activities of plants [47, 48] have been found
to be present in this extract. These compounds may have
been responsible for the antibacterial activity observed in
this study.
CONCLUSION
From the results of this study, the root extract/
fractions possess significant CNS depressant and
anticonvulsant activities as well as a considerable
antibacterial activity. It will be interesting to isolate and
characterised the active ingredient in this extract
CONFLICT OF INTEREST There is no conflict of interest.
ACKNOWLEDGEMENT The authors are grateful to Mr. Nsikan Malachy
Udo of Department of Pharmacology and Toxicology for
technical assistance.
REFERENCES
1. Dalziel JM. Useful Plants of West Tropical Africa, Crown Agents for Overseas Government, London, 1956. 2. Okokon JE, Ita BN, Udokpoh AE.The in vivo antimalarial activities of Uvaria echamae and Hippocratea africana.
Ann Trop Med Parasitol. 100, 2006, 585 - 590.
3. Etukudo I. Forests, Our Divine Treasure. Dorand Publishers, Nigeria,2000, 156 - 180.
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 152 ~
4. Etukudo I. Ethnobotany, Conventional and Traditional Uses of Plants. The Verdict Press, Nigeria, 2003, 83 134. 5. Ajibesin KK, EkpoBA, Bala DN, Essien EE, Adesanya SA. Ethnobotanical survey of Akwa Ibom State of Nigeria.
J Ethnopharmacol,115, 2008, 387 408. 6. Okokon JE, Antia BS, Umoh EE.Analgesic and anti-inflammatory activities of Hippocratea africana.Int J Pharmacol, 4,
2008,51 55. 7. Okokon JE, Akpan HD, Ekaidem I, Umoh EE. Antiulcer and antidiarrhoealactivities of Hippocratea africana.Pak J
Pharmaceut Sci, 24, 2011, 201205. 8. Okokon JE,Antia BS,Umoh EE, Etim EI.Antidiabetic and hypolipidaemic activities of Hippocratea africana.Int. Journal
of Drug Devand Res, 2, 2010, 501 -506.
9. Okokon JE, Dar A, Choudhary MI. Cellular Antioxidant, Cytotoxic and Antileishmanial activities of Hippocratea africana. J Nat Pharmaceuticals, 4(2), 2013, 81 85.
10. Okokon JE, Nwafor PA, Ukeme C. Choudhary MI, Dar A. Antioxidative burst and hepatoprotective effects ofethanol root extract of Hippocratea africana against Paracetamol-induced liver injury. Pharmaceutical Biology, 51(7), 2013, 872
- 880.
11. Archer J. Tests for emotionality in mices and mice, a review. Anim Behav, 21, 1973, 205 - 235. 12. Porsolt RD, Bertin A, Jalfre M. Behavioural despair in mice, a primary screening test for antidepressants. Archives
Internationales de Pharmacodynamieet de Therapie, 229, 1977, 327 - 336.
13. Porsolt RD, Anton G, Deniel M, Jalfre M. Behavioural despair in rats, a new model sensitive to antidepressant treatments. Eur J Pharmacol, 47, 1978, 379 - 391.
14. Steru L, Chermat R, Thierry B, Simon P.The tail suspension test, a new method for screening antidepressants in mice. Psychopharmacology, 85, 1985, 367 - 370.
15. Vellucci SV and Webster RA.Antagonism of caffeine-induced seizures in mice by Ro. 15-1788. European Journal of Pharmacology, 97, 1984, 289-293.
16. Amabeoku GJ, Chikuni O. Cimetidine induced seizures in mice, antagonism by some gabaergicagents. Biochem Pharmacol, 46, 1993, 2171 - 2175.
17. Juliet J, Subramanyam K, SureshS. Individual and combined effects of N6-cyclopentyladenosine, flunarizine and diazepam on aminophylline induced recurrent generalized seizures in mice. Polish J Pharmacol, 55, 2003, 559 - 564.
18. Berghe VA, Vlietinek AJ. Screening methods for anti-bacterial and antiviral agents from higher plants. Methods for Plant Biochem, 6, 1991,47 - 68.
19. Lyudmila B, Sirigan D, Radka K, Nikolai K, Galina G, Ivan M, Rossen N and Zacharii K. Inhibition of Helicobacter pylori growth in vitro by Bulgarian propolis preliminary report. J Med Microb, 52, 2003,417-419.
20. Ozturk Y, Aydini S, Beis R, Baser KHC, Berberoglu H. Effect of Hypericum pericum L. and Hypericum calycinum l. extracts on the central nervous system in mice, Phytomedicine, 3(2), 1996, 139 - 146.
21. Kolawole OT, Makinde JM, Olajide OA. Central nervous system depressant activity of Russeliae quisetiformis. Nig J Physiol Sci, 22(1-2), 2007, 59-63.
22. Yadav AV, Kawale LA, Nade VS. Effect of Morus alba L leaves on anxiety in mice. Ind J Pharmacol,40(1),2008,32-36. 23. Hemby SE, Lucki I, Gatto G, Singh A, Thornley C, Matasi J. Potential antidepressant effects of novel tropane
compounds, selective for serotonin and dopamine transporters. J Pharmacol Experimental Therapeutics, 282,1997, 727 -
733.
24. Dhingra D, Sharma A. Evaluation of antidepressant-like activity of glycyrrhizin in mice. Ind J Pharmacol, 37(6), 2005, 390-394.
25. Lucki, I. The forced swimming test as a model for core and component behavioural effects of antidepressant drugs. BehaviouralPharmacol, 8, 1997, 523 - 532.
26. Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology, 121, 1995, 6672.
27. Willner P. The validity of animal models of depression. Psychopharmacology, 83,1984, 116. 28. Hossain MM, Biva IJ, Jahangir R, Vhuiyan MMI. CNS depressant and analgesic activity of Aphanamixis polystachya
(wall.) parker leaf extract in mice. Afr J Pharm Pharmacol, 3(5), 2009, 282 - 286.
29. Noldner M, Schotz K. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Medica, 68, 2002, 577 - 580.
30. Chu NS. Caffeine and aminophylline-induced seizures, Epilepsia, 22, 1981, 85 -95. 31. Jensen MH, Jorgensen S, Nielsen H, et al. Is theophylline-induced seizure in man caused by inhibition of cerebral -
nucleotidase activity. Acta of Pharmacology and Toxicology, 55, 1984, 331-334.
32. Sharma A, Sandhir R. Oxidative stress after lithium-pilocarpine induced status epilepticus in mice brain. Annals of Neurosciences, 13(1), 2006,1 - 4.
-
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.
~ 153 ~
33. Daval J, Nehlig A, Nicholas F. Physiological & Pharmacological properties of adenosine, Therapeutic implications. Life Sciences, 49, 1991, 1435 - 53.
34. Neering IR, Me Burney RM. Role for microsomal calcium storage in mam-malian neurons? Nature (London), 309, 1984, 158 -160.
35. Tutka P, Turski WA, Kleinrok Z. Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice. Journal of Neural Transmission,
103, 1996, 307-314.
36. Ray A, Gulati K, Anand S, Vijayan V. Pharmacological studies on mechanisms of aminophylline induced seizures in rats. Ind J ExplBiol, 43, 2005, 849-853.
37. Sayyah M, Kamalinejad M, Hidage RB, Rustaiyan, A. Antiepileptic potential and composition of the fruit essential oil of Ferula gummosaboiss. Iran Biomed, J, 5, 2001, 69-72.
38. Almeida R N, Agra M F,Maior FN, de Sousa D. P. Essential Oils and Their Constituents, Anticonvulsant Activity. Molecules, 16, 2011, 2726 -2742.
39. De Sarro A, Cecchetti V, Fravlini V, Naccari F, Tabararrini O, De Sarro G. Effect of novel 6- desfluoroquinolones and classic quinolones on pentylene tetrazole induced seizures in mice. Antimicrob Agents Chemother, 43,1999, 1729 1736.
40. GaleK.(1992).GABA and epilepsy, Basic concepts from preclinical research.Epilepsia, 33,1992, S3 S12. 41. WestmorelandBF,BenarrochEE,DubeJR,ReganTJ,Sandok BA. Medical Neurosciences.Mayo Foundation ,Rochester.
1994, 307 312. 42. Porter RJ, Meldrum BS. Antiseizure drugs. In, Katzung BG. (Ed), Basic and Clinical Pharmacology. 8th ed. Lange
Medical Books/McGraw-hill, New York,2001, 403 417. 43. Rang HP, Dale MM, Ritter JM, Moore P K. Pharmacology, 5th ed.Churchill Livingstone. Edinburg, 2003, 557 - 587. 44. Amabeoku GJ, Green I, Kabatende J. Anticonvulsant activity of Cotyledon orbiculata L. (Crassulaceae) leaf extract in
mice. Journal of Ethnopharmacology, 112, 2007, 101107. 45. Nyeem MAB, Alam MA, Awal MA, Mostofa M, Uddin SJ, Islam N, Rouf R. CNS depressant effect of the crude
ethanolic extract of the flowering tops of Rosa damascena. Iranian J Pharmacol Ther, 5, 2006, 171-174.
46. RaquibulHasan SM, Hossain MM, Akter R, Jamila M, Mazumder EHM, Rahman S. Sedative and anxiolytic effects of different fractions of the Commelina benghalensis Linn. Drug Discov Ther, 3, 2009,221- 227.
47. Habtemariam S, Gray AI, Waterman PG. A new antibacterial sesquiterpenes from Premna aligotricha. J Nat Prod, 56, 1993, 3864 - 74.
48. Uma B, Parvathavarthini R. Antibacterial Effect of Hexane Extract of Sea Urchin, Temnopleurus alexandri. Inter JPharmTechRes, 2, 2010, 1677 - 1680.